According to research published by the British Medical Journal (BMJ), those using weight-loss injection drugs could also regain weight almost four times faster than they would after dieting once they ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...

Learn the psychology behind win goals. We also explain the "stop loss" trap and how to set flexible, behavior based goals while gambling. Every casino player dreams of walking away a winner, and most ...

Over half a million Californians could lose access to the hugely popular GLP-1 weight loss drugs starting Jan. 1, 2026, after the state government decided to deny some Medi-Cal coverage for the ...

Eric Idle says political correctness means there won’t be another Monty Python. The 82-year-old comic was part of the comedy troupe along with John Cleese, Sir Michael Palin, Terry Gilliam and the ...

The Detroit Lions took ownership of two offensive pass interference penalties at the end of Sunday's 29-24 loss to the Pittsburgh Steelers that wiped out potential game-winning scores. "We weren't ...

Relationships form through memories filled with emotion and images. When a relationship ends, we might wonder why our thoughts seem cloudy. Loss and grief, from many circumstances, can cause cognitive ...

Pumping iron isn’t the only way to pump the brakes on age-related muscle loss. While weight training has long been lauded as the key to building and maintaining muscle mass, experts say there are ...

From Ozempic to Wegovy to Mounjaro, injectable weight-loss drugs have become household names — and now there’s a new one everyone is talking about. Retatrutide, a once-weekly experimental injection, ...

In two recent videos, the late rocker's daughter said she's been struggling to eat: "My life is completely flipped upside down." Mekishana Pierre is a news writer at Entertainment Weekly. She has been ...

Starting Jan. 1, New Hampshire’s Medicaid program will stop covering GLP-1 drugs — Wegovy, Zepbound, and others — for weight loss, the state Department of Health and Human Services told providers in ...

A stop-loss order is a tool that helps investors manage risk. It automatically sells a stock when the price drops to a certain level, helping you avoid larger losses if the market turns against you.